SNGLR Capital is focused on investments in the sectors longevity and smart mobility/ smart cities, and lead exponential technologies such as AI or blockchain. „Our investment thesis focuses, among other things, on applications in the field of personal medicine with strong growth potential. We see these points very well supported by Cellestia. Above all, the advanced phase II study data allow an investment with less risk compared to other early-stage investment rounds.“ says Dr.med Eszter Tanzcos Olver, Lead Partner Longevity SNGLR Capital.
“We were very impressed by the promising Phase I data with sign of clinical efficacy of the CB-103, a first-in-class small molecule targeted therapy with a novel mode of action, and the efficiency of the Cellestia team. It is very exciting, to contribute with our investment, to help many people who today have no treatment option with this new therapy tailored to the oncology profile of an individual patient.” says Klaus Kummermehr, CEO of SNGLR Capital.
Cellestia is a clinical stage R&D company developing innovative first-in-class therapies to control and modulate pathogenic gene expression in multiple disease areas by selective inhibition of transcription factors in the cell nucleus. The lead compound CB-103 has advanced to Phase 2 successfully treating patients with multi-drug resistant cancers.
SNGLR Capital AG which is in the process of raising a seed venture capital fund is the venture capital entity within the SNGLR Group. The Group which was founded by Daniel Diemers, Klaus Kummermehr, Dr. Patrick Sutter and Luca Sambucci and joined by several experienced partners has two other entities, beside the Capital team: SNGLR Digital and SNGLR XLabs. SNGLR Digital includes a team of skilled and diverse advisors & consultants with strong capabilities ranging from strategy to digital innovation, M&A, marketing and data analytics. The aim is to excel and help clients and startups solve the greatest challenges around exponential technologies. A group of highly skilled IT Gurus & deep tech devs are working for SNGLR XLabs. They build bespoke solutions for clients as well as internal applications, leveraging the latest technologies (AI, blockchain, etc.)
(Press release / SK)
Please login or sign up to comment.
Commenting guidelines